Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model


Bakir M., Turel O., Topachevskyi O.

BMC HEALTH SERVICES RESEARCH, cilt.12, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1186/1472-6963-12-386
  • Dergi Adı: BMC HEALTH SERVICES RESEARCH

Özet

Background: Streptococcus pneumoniae infections, which place a considerable burden on healthcare resources, can be reduced in a cost-effective manner using a 7-valent pneumococcal conjugate vaccine (PCV-7). We compare the cost effectiveness of a 13-valent PCV (PCV-13) and a 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with that of PCV-7 in Turkey.